Ionetix Corp / DE
Lansing, US · Delaware corporation
Founders & leadership
PP
Phieu PhunChief Financial Officer
MS
Michael StewartExecutive Chairman
KC
Kevin CameronChief Executive Officer
Board
DL
David LandskowskyBoard director
DB
Douglas BootheBoard director
GM
Gregory MartinBoard director
Reported raises · per SEC filings
Form D private placements$32.3M disclosed across 1 round · 2026
▶$32.3MraisedApr 2026 · 267 investors · PharmaceuticalsRule 506(b)
▶$32.3MraisedApr 2026 · 267 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Douglas BootheDirector
- Gregory MartinDirector
- David LandskowskyDirector
- Phieu PhunExecutive Officer
- Michael StewartExecutive Officer, Director
- Kevin CameronExecutive Officer
- Offering amount
- $32.3M
- Amount sold
- $32.3M
- Minimum investment
- $100K
- Sales commissions
- $2.6M
- First sale
- Apr 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Ionetix Corp / DE raised?
- Ionetix Corp / DE has disclosed $32.3M raised across 1 round.
- Where is Ionetix Corp / DE headquartered?
- Ionetix Corp / DE is headquartered in Lansing, US.